ONCOCYTE CORP
NASDAQ: OCX (OncoCyte Corporation)
Kemas kini terakhir: 9 jam lalu0.218
-0.02 (-7.67%)
| Penutupan Terdahulu | 0.236 |
| Buka | 0.235 |
| Jumlah Dagangan | 902,396 |
| Purata Dagangan (3B) | 534,972 |
| Modal Pasaran | 35,930,976 |
| Harga / Jualan (P/S) | 12.24 |
| Harga / Buku (P/B) | 7.56 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 8 Aug 2023 - 14 Aug 2023 |
| Margin Operasi (TTM) | -273.01% |
| EPS Cair (TTM) | -3.79 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 1,114.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 34.04% |
| Nisbah Semasa (MRQ) | 3.74 |
| Aliran Tunai Operasi (OCF TTM) | -22.74 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -15.27 M |
| Pulangan Atas Aset (ROA TTM) | -22.17% |
| Pulangan Atas Ekuiti (ROE TTM) | -428.96% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | OncoCyte Corporation | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 0.0 |
| Purata | 0.17 |
|
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 22.03% |
| % Dimiliki oleh Institusi | 56.30% |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |